NIH’s, the ITM’s parent organization, National Institute of Allergy and Infectious Diseases will award $1.2 million to three to five translational research projects focused on development of Multipurpose Prevention Technologies (MPTs) that prevent sexually transmitted infections (STIs), human immunodeficiency virus (HIV) and/or unintended pregnancy. Projects must further the prevention of two or more STIs, an STI and Human Immunodeficiency Virus, or an STI and unintended pregnancies.

Learn more and submit your application.

Source: NIH